Sonal Singh to Drug-Related Side Effects and Adverse Reactions
This is a "connection" page, showing publications Sonal Singh has written about Drug-Related Side Effects and Adverse Reactions.
Pradhan R, Singh S. Comparison of Data on Serious Adverse Events and Mortality in ClinicalTrials.gov, Corresponding Journal Articles, and FDA Medical Reviews: Cross-Sectional Analysis. Drug Saf. 2018 Sep; 41(9):849-857.
Iyer G, Marimuthu SP, Segal JB, Singh S. An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System. Drug Saf. 2017 09; 40(9):799-808.
Singh S, Loke YK. Drug safety assessment in clinical trials: methodological challenges and opportunities. Trials. 2012 Aug 20; 13:138.
McDonough CW, Warren HR, Jack JR, Motsinger-Reif AA, Armstrong ND, Bis JC, House JS, Singh S, El Rouby NM, Gong Y, Mychaleckyj JC, Rotroff DM, Benavente OR, Caulfield MJ, Doria A, Pepine CJ, Psaty BM, Glorioso V, Glorioso N, Hiltunen TP, Kontula KK, Arnett DK, Buse JB, Irvin MR, Johnson JA, Munroe PB, Wagner MJ, Cooper-DeHoff RM. Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies. Clin Pharmacol Ther. 2021 09; 110(3):723-732.
Loke YK, Ho R, Smith M, Wong O, Sandhu M, Sage W, Singh S. Systematic review evaluating cardiovascular events of the 5-alpha reductase inhibitor - Dutasteride. J Clin Pharm Ther. 2013 Oct; 38(5):405-15.
Singh S, Nautiyal A. Secondary hypertension due to drugs and toxins--a challenge for research on harm. South Med J. 2007 Jul; 100(7):665-6.